|
Report No. : |
334706 |
|
Report Date : |
03.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
A&A PHARMACHEM INC. |
|
|
|
|
Registered Office : |
77 Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7 |
|
|
|
|
Country : |
Canada |
|
|
|
|
Date of Incorporation : |
24.10.1991 |
|
|
|
|
Legal Form : |
Corporation – Profit |
|
|
|
|
Line of Business : |
Subject distributes pharmaceutical, over the counter, nutraceutical, and
sports nutrition ingredients, as well as finished products to pharmaceutical
and nutraceutical product manufacturers and marketers primarily in Canada,
the United States, Europe, and Australia. Its nutraceutical ingredients
include botanical extracts and powders, specialty ingredients, amino acids
and derivatives, minerals, sweeteners, proteins, enzymes and blends, vitamins
and blends, excipients, and essential and carrier oils. The company’s sports
nutrition ingredients comprise creatine monohydrate, L-glutamine and branched
chain amino acids, and amino acid nitrates, as well as dairy and other animal
derived proteins and vegetarian proteins, including whey protein concentrates
and whey protein isolates. It also offers technical support services. |
|
|
|
|
No. of Employees : |
12 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Canada |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CANADA - ECONOMIC OVERVIEW
As a high-tech industrial society in the trillion-dollar
class, Canada resembles the US in its market-oriented economic system, pattern of
production, and high living standards. Since World War II, the impressive
growth of the manufacturing, mining, and service sectors has transformed the
nation from a largely rural economy into one primarily industrial and urban.
The 1989 US-Canada Free Trade Agreement (FTA) and the 1994 North American Free
Trade Agreement (NAFTA) (which includes Mexico) touched off a dramatic increase
in trade and economic integration with the US, its principal trading partner.
Canada enjoys a substantial trade surplus with the US, which absorbs about
three-fourths of Canadian merchandise exports each year. Canada is the US's
largest foreign supplier of energy, including oil, gas, and electric power, and
a top source of US uranium imports. Given its abundant natural resources,
highly skilled labor force, and modern capital plant, Canada enjoyed solid
economic growth from 1993 through 2007. Buffeted by the global economic crisis,
the economy dropped into a sharp recession in the final months of 2008, and
Ottawa posted its first fiscal deficit in 2009 after 12 years of surplus.
Canada's major banks, however, emerged from the financial crisis of 2008-09
among the strongest in the world, owing to the early intervention by the Bank
of Canada and the financial sector's tradition of conservative lending
practices and strong capitalization. Canada achieved marginal growth in 2010-14
and plans to balance the budget by 2015 despite the recent drop in oil prices.
In addition, the country's petroleum sector is rapidly expanding, because Alberta's
oil sands significantly boosted Canada's proven oil reserves. Canada now ranks
third in the world in proved oil reserves behind Saudi Arabia and Venezuela and
is the world’s fifth-largest oil producer.
|
Source
: CIA |
Company name: A&A PHARMACHEM INC.
Address: 77
Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7 - Canada
Telephone: +1
613-228-2600
Fax: +1 613-224-0444
Website: www.aapharmachem.com
Corporate ID#: ON-0000951172
State: Ontario
Judicial form: Corporation – Profit
Date incorporated: 10-24-1991
Stock: -
Value: -
Name of manager: ATUL
S. AGGARWAL
Business:
A&A Pharmachem Inc. distributes pharmaceutical, over the counter,
nutraceutical, and sports nutrition ingredients, as well as finished products
to pharmaceutical and nutraceutical product manufacturers and marketers
primarily in Canada, the United States, Europe, and Australia. Its
nutraceutical ingredients include botanical extracts and powders, specialty
ingredients, amino acids and derivatives, minerals, sweeteners, proteins,
enzymes and blends, vitamins and blends, excipients, and essential and carrier
oils. The company’s sports nutrition ingredients comprise creatine monohydrate,
L-glutamine and branched chain amino acids, and amino acid nitrates, as well as
dairy and other animal derived proteins and vegetarian proteins, including whey
protein concentrates and whey protein isolates. It also offers technical
support services.
A&A Pharmachem serves brand name and private label manufacturers.
The company was founded in 1991 and is based in Ottawa, Canada with an
additional office in Mumbai, India.
It also has warehouses in Denver, Colorado; Chicago, Illinois; New
Jersey; Ontario; Manitoba; and British Columbia.
Staff: 12
Operations & branches:
At above address, we find
the corporate office.
Shareholders:
This is a AGGARWAL family owned and managed company.
Management:
Atul S. AGGARWAL is the
President, Director and CEO.
Graduate from Wilfrid
Laurier University in 1989 with a MBA in Administration.
Nav AGGARWAL is Director
As far as we know, they are
involved in other corporations, including:
INTERNATIONAL PHARMACEUTICAL GENERICS LTD
77 Auriga Drive, Ste 4, Ottawa, Ontario K2E 7Z7
Incorporated in Ontario on 11-18-2008
ID# ON-0001663300
In Canada, privately held
corporations are not required to publish any financials.
On a direct call, a sales
assistant controlled the present report but deferred any financials.
We sent a fax but no answer
received.
Outside sources (bank) gave
estimate sales for year 2014 up to
CAD 32,000,000= verse USD
30,000,000= in 2013.
The business is profitable.
Banks: Royal Bank of Canada
...
Legal filings & complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts summary: None
Trade references:
Date reported: July 2015
High credit: CAD 8,000
Now owing: 0
Past due: 0
Last purchase: June 2015
Line of business: Office supply
Paying status: On terms
Date reported: July 2015
High credit: CAD 20,000+
Now owing: 0
Past due: 0
Last purchase: June 2015
Line of business: Payroll
Paying status: As agreed
Date reported: July 2015
High credit: CAD 620
Now owing: 0
Past due: 0
Last purchase: June 2015
Line of business: Telecommunications
Paying status: On terms
Domestic credit history:
National Credit Bureaus
gave a satisfying credit rating.
According to our credit analysts, during the last 6 months, payments of
imports were currently made on terms.
The Company maintains a
regular business.
The Company is in good
standing.
This means that all local
and federal taxes were paid on due date.
The risk is low.
Our opinion:
A business connection may
be conducted.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.00 |
|
|
1 |
Rs.99.84 |
|
Euro |
1 |
Rs.70.16 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as
a reference to assess SC’s credit risk and to set the amount of credit to be extended.
It is calculated from a composite of weighted scores obtained from each of the
major sections of this report. The assessed factors and their relative weights
(as indicated through %) are as follows:
Financial
condition (40%) Ownership background
(20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)